These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 7904547)
21. Effects of auranofin and other antirheumatic drugs on human myelopoiesis in vitro. Hamilton JA; Williams N J Rheumatol; 1987 Apr; 14(2):216-20. PubMed ID: 2885415 [TBL] [Abstract][Full Text] [Related]
22. Drugs for rheumatoid arthritis. Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134 [No Abstract] [Full Text] [Related]
23. Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice. Crossley MJ; Spowage M; Hunneyball IM Drugs Exp Clin Res; 1987; 13(5):273-7. PubMed ID: 2890505 [TBL] [Abstract][Full Text] [Related]
24. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis. Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721 [TBL] [Abstract][Full Text] [Related]
25. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. Wolfe F; Hawley DJ; Cathey MA J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of hydroxychloroquine as an antirheumatic drug. Fox RI Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):82-91. PubMed ID: 8278823 [TBL] [Abstract][Full Text] [Related]
31. Drug therapy for juvenile arthritis. Duffy CM; Laxer RM; Silverman ED Compr Ther; 1989 Oct; 15(10):48-59. PubMed ID: 2572375 [TBL] [Abstract][Full Text] [Related]
32. D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study. Eberhardt K; Rydgren L; Fex E; Svensson B; Wollheim FA Clin Exp Rheumatol; 1996; 14(6):625-31. PubMed ID: 8978957 [TBL] [Abstract][Full Text] [Related]
33. Antimalarial drug induced decrease in creatinine clearance. Landewé RB; Vergouwen MS; Goeei The SG; Van Rijthoven AW; Breedveld FC; Dijkmans BA J Rheumatol; 1995 Jan; 22(1):34-7. PubMed ID: 7699677 [TBL] [Abstract][Full Text] [Related]
34. Bioavailability of hydroxychloroquine tablets in healthy volunteers. Tett SE; Cutler DJ; Day RO; Brown KF Br J Clin Pharmacol; 1989 Jun; 27(6):771-9. PubMed ID: 2757893 [TBL] [Abstract][Full Text] [Related]
35. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments. Simon LS Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314 [TBL] [Abstract][Full Text] [Related]
36. [A comparative evaluation of parenteral and oral preparations of gold and D-penicillamine in the treatment of rheumatoid nephropathy]. Chichasova NV; Kanevskaia MZ; Slobodina GA; Varshavskiĭ VA; Krel' OV; Krel' AA Ter Arkh; 1991; 63(5):97-101. PubMed ID: 1679571 [TBL] [Abstract][Full Text] [Related]
38. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists. van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132 [TBL] [Abstract][Full Text] [Related]
39. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis. Clegg DO; Ward JR Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451 [TBL] [Abstract][Full Text] [Related]
40. Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. Brewer EJ; Giannini EH; Kuzmina N; Alekseev L N Engl J Med; 1986 May; 314(20):1269-76. PubMed ID: 3517643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]